Elizabeth E. Reed

CIK: 0001283303

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)25 (58.1%)

Position reduction

Option Exercises (M)13 (30.2%)

Derivative conversions

Awards (A)5 (11.6%)

Compensation grants

Other (G, F, J, C, D, …)0 (0.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

TVTX

Travere Therapeutics, Inc.

Officer

Discretionary Trading P&L

Holdings

Transaction History (43 total)

TVTX
Travere Therapeutics, Inc.
Sep 15, 2026
Sale(S)
Direct
1.4K shares at avg. $63.69$89K
TVTX
Travere Therapeutics, Inc.
Sep 15, 2026
Sale(S)
Direct
21.9K shares at avg. $62.03$1.4M
TVTX
Travere Therapeutics, Inc.
Sep 15, 2026
Exercise(M)
Direct
37.5K shares at avg. $15.46$580K
TVTX
Travere Therapeutics, Inc.
Sep 15, 2026
Sale(S)
Direct
300 shares at avg. $65.31$20K
TVTX
Travere Therapeutics, Inc.
Sep 15, 2026
Sale(S)
Direct
13.9K shares at avg. $62.63$869K
TVTX
Travere Therapeutics, Inc.
May 6, 2026
Sale(S)
Direct
2.1K shares at avg. $43.95$91K
TVTX
Travere Therapeutics, Inc.
May 5, 2026
Sale(S)
Direct
2.2K shares at avg. $46.65$101K
TVTX
Travere Therapeutics, Inc.
May 4, 2026
Sale(S)
Direct
20K shares at avg. $45.00$900K
TVTX
Travere Therapeutics, Inc.
May 4, 2026
Award(A)
Performance-based restricted stock units
Direct
8.5K shares-
TVTX
Travere Therapeutics, Inc.
May 4, 2026
Exercise(M)
Direct
4.3K shares-
TVTX
Travere Therapeutics, Inc.
May 4, 2026
Exercise(M)
Direct
20K shares at avg. $17.96$359K
TVTX
Travere Therapeutics, Inc.
Apr 15, 2026
Sale(S)
Direct
1.6K shares at avg. $42.53$66K
TVTX
Travere Therapeutics, Inc.
Apr 15, 2026
Sale(S)
Direct
5.2K shares at avg. $41.62$218K
TVTX
Travere Therapeutics, Inc.
Apr 14, 2026
Sale(S)
Direct
7.2K shares at avg. $41.93$303K
TVTX
Travere Therapeutics, Inc.
Apr 14, 2026
Exercise(M)
Direct
10K shares at avg. $19.08$191K
TVTX
Travere Therapeutics, Inc.
Apr 14, 2026
Exercise(M)
Direct
20K shares at avg. $17.96$359K
TVTX
Travere Therapeutics, Inc.
Apr 14, 2026
Exercise(M)
Direct
7.5K shares at avg. $15.46$116K
TVTX
Travere Therapeutics, Inc.
Apr 14, 2026
Sale(S)
Direct
37.5K shares at avg. $41.07$1.5M
TVTX
Travere Therapeutics, Inc.
Apr 13, 2026
Award(A)
Direct
14K shares-
TVTX
Travere Therapeutics, Inc.
Apr 1, 2026
Sale(S)
Direct
10K shares at avg. $30.00$300K
TVTX
Travere Therapeutics, Inc.
Apr 1, 2026
Exercise(M)
Direct
10K shares at avg. $15.46$155K
TVTX
Travere Therapeutics, Inc.
Mar 16, 2026
Sale(S)
Direct
10K shares at avg. $28.09$281K
TVTX
Travere Therapeutics, Inc.
Mar 16, 2026
Exercise(M)
Direct
10K shares at avg. $19.08$191K
TVTX
Travere Therapeutics, Inc.
Feb 17, 2026
Sale(S)
Direct
4.3K shares at avg. $28.26$122K
TVTX
Travere Therapeutics, Inc.
Feb 17, 2026
Exercise(M)
Direct
10K shares at avg. $19.08$191K

		Type	Shares	Price		Ownership
Sep 15, 2026	TVTX Travere Therapeutics, Inc.	Sale(S)	1,400	$63.69	$89,166	Direct
Sep 15, 2026	TVTX Travere Therapeutics, Inc.	Sale(S)	21,926	$62.03	$1,359,971	Direct
Sep 15, 2026	TVTX Travere Therapeutics, Inc.	Exercise(M)	37,500	$15.46	$579,750	Direct
Sep 15, 2026	TVTX Travere Therapeutics, Inc.	Sale(S)	300	$65.31	$19,593	Direct
Sep 15, 2026	TVTX Travere Therapeutics, Inc.	Sale(S)	13,874	$62.63	$868,965	Direct
May 6, 2026	TVTX Travere Therapeutics, Inc.	Sale(S)	2,076	$43.95	$91,240	Direct
May 5, 2026	TVTX Travere Therapeutics, Inc.	Sale(S)	2,174	$46.65	$101,417	Direct
May 4, 2026	TVTX Travere Therapeutics, Inc.	Sale(S)	20,000	$45.00	$900,000	Direct
May 4, 2026	TVTX Travere Therapeutics, Inc.	Award(A) Performance-based restricted stock units	8,500	-	-	Direct
May 4, 2026	TVTX Travere Therapeutics, Inc.	Exercise(M)	4,250	-	$0	Direct
May 4, 2026	TVTX Travere Therapeutics, Inc.	Exercise(M)	20,000	$17.96	$359,200	Direct
Apr 15, 2026	TVTX Travere Therapeutics, Inc.	Sale(S)	1,559	$42.53	$66,304	Direct
Apr 15, 2026	TVTX Travere Therapeutics, Inc.	Sale(S)	5,226	$41.62	$217,506	Direct
Apr 14, 2026	TVTX Travere Therapeutics, Inc.	Sale(S)	7,215	$41.93	$302,516	Direct
Apr 14, 2026	TVTX Travere Therapeutics, Inc.	Exercise(M)	10,000	$19.08	$190,800	Direct
Apr 14, 2026	TVTX Travere Therapeutics, Inc.	Exercise(M)	20,000	$17.96	$359,200	Direct
Apr 14, 2026	TVTX Travere Therapeutics, Inc.	Exercise(M)	7,500	$15.46	$115,950	Direct
Apr 14, 2026	TVTX Travere Therapeutics, Inc.	Sale(S)	37,500	$41.07	$1,540,125	Direct
Apr 13, 2026	TVTX Travere Therapeutics, Inc.	Award(A)	14,000	-	$0	Direct
Apr 1, 2026	TVTX Travere Therapeutics, Inc.	Sale(S)	10,000	$30.00	$300,000	Direct
Apr 1, 2026	TVTX Travere Therapeutics, Inc.	Exercise(M)	10,000	$15.46	$154,600	Direct
Mar 16, 2026	TVTX Travere Therapeutics, Inc.	Sale(S)	10,000	$28.09	$280,861	Direct
Mar 16, 2026	TVTX Travere Therapeutics, Inc.	Exercise(M)	10,000	$19.08	$190,800	Direct
Feb 17, 2026	TVTX Travere Therapeutics, Inc.	Sale(S)	4,321	$28.26	$122,120	Direct
Feb 17, 2026	TVTX Travere Therapeutics, Inc.	Exercise(M)	10,000	$19.08	$190,800	Direct

1-25 of 43 transactions

About REED ELIZABETH E

REED ELIZABETH E (SEC CIK 0001283303) files insider reports with the SEC as Chief Legal Officer and GC of Travere Therapeutics, Inc. (TVTX).

Signal8 holds 15 ownership filings by REED ELIZABETH E, all Form 4s, filed between Sep 9, 2024 and Sep 17, 2026. Those filings report 43 transactions, from Sep 5, 2024 to Sep 15, 2026. Signal8's Form 4 history starts in Sep 2024.

The business address on REED ELIZABETH E's filings is in SAN DIEGO, CA.

Recent filings by REED ELIZABETH E

Sep 15, 2026: Open-market sales of TVTX shares (2 lines, Form 4, code S).
Sep 15, 2026: Option exercise of TVTX shares (Form 4, code M).
Sep 15, 2026: Open-market sales of TVTX shares (2 lines, Form 4, code S).
May 6, 2026: Open-market sale of TVTX shares (Form 4, code S).
May 5, 2026: Open-market sale of TVTX shares (Form 4, code S).

Other insiders filing for Travere Therapeutics, Inc. (TVTX)

Dube Eric M, CHIEF EXECUTIVE OFFICER
ROTE WILLIAM E., Chief Research Officer
Heerma Peter, EVP, CHIEF COMMERCIAL OFFICER
Inrig Jula, EVP, Head of R&D & CMO
Cline Christopher R., CHIEF FINANCIAL OFFICER
Calvin Sandra, SVP, CHIEF ACCOUNTING OFFICER

How to read Form 4 transaction codes